Financial results - PHARMAEXCELL S.R.L.

Financial Summary - Pharmaexcell S.r.l.
Unique identification code: 40019002
Registration number: J2018015032400
Nace: 4727
Sales - Ron
87.950
Net Profit - Ron
41.629
Employees
1
Open Account
Company Pharmaexcell S.r.l. with Fiscal Code 40019002 recorded a turnover of 2024 of 87.950, with a net profit of 41.629 and having an average number of employees of 1. The company operates in the field of Comerţ cu amănuntul al altor produse alimentare having the NACE code 4727.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Pharmaexcell S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - - 368 14.258 14.496 74.279 87.950
Total Income - EUR - - - - - 421 14.264 14.676 74.294 88.243
Total Expenses - EUR - - - - - 1.503 7.674 15.160 54.944 43.763
Gross Profit/Loss - EUR - - - - - -1.082 6.590 -484 19.350 44.480
Net Profit/Loss - EUR - - - - - -1.097 5.873 -1.152 16.410 41.629
Employees - - - - - 0 0 0 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 19.1%, from 74.279 euro in the year 2023, to 87.950 euro in 2024. The Net Profit increased by 25.310 euro, from 16.410 euro in 2023, to 41.629 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Pharmaexcell S.r.l.

Rating financiar

Financial Rating -
PHARMAEXCELL S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Pharmaexcell S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Pharmaexcell S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Pharmaexcell S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Pharmaexcell S.r.l. - CUI 40019002

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - - 0 11.240 9.824 11.345 6.861
Current Assets - - - - - 11.852 30.226 36.783 65.365 131.418
Inventories - - - - - 3.012 9.222 5.449 8.426 42.884
Receivables - - - - - 4 12.356 12.515 31.572 41.931
Cash - - - - - 8.836 8.648 18.819 25.367 46.603
Shareholders Funds - - - - - -1.113 4.785 3.648 20.047 61.563
Social Capital - - - - - 41 40 41 40 40
Debts - - - - - 12.965 36.682 42.959 56.663 76.716
Income in Advance - - - - - 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4727 - 4727"
CAEN Financial Year 4791
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 131.418 euro in 2024 which includes Inventories of 42.884 euro, Receivables of 41.931 euro and cash availability of 46.603 euro.
The company's Equity was valued at 61.563 euro, while total Liabilities amounted to 76.716 euro. Equity increased by 41.628 euro, from 20.047 euro in 2023, to 61.563 in 2024.

Risk Reports Prices

Reviews - Pharmaexcell S.r.l.

Comments - Pharmaexcell S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.